Welcome to our dedicated page for Bionoid Pharma news (Ticker: BINP), a resource for investors and traders seeking the latest updates and insights on Bionoid Pharma stock.
AI Maverick Intel Inc. (BINP), formerly Bionoid Pharma Inc., reports developments around its transition into an AI-focused operating company and the commercialization of its proprietary AI Maverick platform. News themes include AI-powered prospecting, human-like customer engagement, contact intelligence, context-aware communication, and platform uses across healthcare, biotech, insurance, transportation and other sales-driven markets.
Company updates also cover the completed Delaware name change from Bionoid Pharma, the acquisition and rollout of the AI Maverick platform, financial-audit milestones, auditor engagement, corporate communications initiatives and OTC market-related governance disclosures.
Summary not available.
Summary not available.
Summary not available.
Bionoid Pharma, Inc. (BINP) announced a Letter of Intent to acquire Global Alerts Corp., aiming to deliver a mass notification platform for the 6 billion people lacking emergency alert systems. This acquisition promises international growth opportunities, leveraging Global Alerts' exclusive rights to develop the UPSEN platform under contract with One World UPSEN Alliance. The UPSEN platform will enable emergency messaging through commercial wireless carriers, providing crucial alerts to mobile devices in participating nations. This strategic move is anticipated to expand BINP's market reach and enhance its position in the health and wellness sector.